Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultrastruct Pathol ; 34(5): 307-13, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20929308

RESUMO

Fabry's disease is an X-linked error of metabolism with deficiency of the enzyme α-glycosidase A, and glycosphingolipid accumulation in multiple tissues. Patients may be asymptomatic and present with advanced disease. We report a case of a 38 year old white male who presented with end stage renal disease of unknown etiology. He received a living-related donor kidney transplant (mother), but lost the graft after 10 years to multiple episodes of rejection. Review of the native renal biopsy with added ultrastructural studies established the diagnosis of Fabry's disease. Evaluation of renal biopsies showing advanced chronic injury should include electron microscopic studies, which may reveal characteristic diagnostic features, as seen in this case of Fabry's disease. Identification of hereditary disorders involving the kidney is important for appropriate treatment and prevention of disease recurrence. Potential living related donors should be screened for genetic involvement.


Assuntos
Doença de Fabry/patologia , Falência Renal Crônica/patologia , Rim/ultraestrutura , Adulto , Doença de Fabry/complicações , Doença de Fabry/cirurgia , Rejeição de Enxerto , Humanos , Falência Renal Crônica/etiologia , Falência Renal Crônica/cirurgia , Transplante de Rim , Masculino , Microscopia Eletrônica de Transmissão , Adulto Jovem
3.
Am J Hematol ; 83(10): 811-4, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18756543

RESUMO

Thrombotic thrombocytopenic purpura (TTP) is often associated with acquired or congenital deficiency of the von Willebrand factor-cleaving metalloprotease, ADMATS13 (Lammle B et al., J Thromb Haemost 2005;3:1663-1675; Schneppenheim et al., Blood 2003;101:1845-1850). Although undetectable levels of enzyme activity (<10%) are diagnostic of inherited or acquired TTP in the correct clinical setting (absence is specific), not all patients diagnosed with TTP have severe protease deficiency, and it is therefore not recommended as an initial test for diagnosis (Copelovitch and Kaplan, Pediatr Nephrol, in press). Many prospective and retrospective studies have demonstrated that patients with severe protease deficiency have a higher likelihood of relapse, making it helpful as an indicator of recurrence. The short-term prognostic usefulness of ADAMTS13 testing during acute TTP warrants further investigation because of limited prospective studies (Ferrari S et al., Blood 2007;109:2815-2822; Peyvandi et al., Haematologica 2008;93:232-239).


Assuntos
Proteínas ADAM/antagonistas & inibidores , Proteínas ADAM/metabolismo , Inibidores Enzimáticos , Proteínas ADAM/sangue , Proteínas ADAM/genética , Proteína ADAMTS13 , Ensaio de Imunoadsorção Enzimática , Transferência Ressonante de Energia de Fluorescência , Genes Recessivos , Heterozigoto , Homozigoto , Peroxidase do Rábano Silvestre/metabolismo , Humanos , Peso Molecular , Mutação , Troca Plasmática/efeitos adversos , Estrutura Terciária de Proteína , Púrpura Trombocitopênica Trombótica/sangue , Púrpura Trombocitopênica Trombótica/diagnóstico , Púrpura Trombocitopênica Trombótica/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Padrões de Referência , Sensibilidade e Especificidade , Especificidade por Substrato , Fator de von Willebrand/química , Fator de von Willebrand/genética , Fator de von Willebrand/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...